Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion

Inversago's drugs use a different approach than most treatments in the obesity and diabetes space.

from Health and Science https://ift.tt/VGcCTRy
https://ift.tt/ifMVQG7
https://ift.tt/w74Ooc1